Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter November 21, 2013

Glucagon and insulin cord blood levels in very preterm, late preterm and full-term infants

  • Franco Bagnoli EMAIL logo , Frida Vodo , Stela Vodo , Maria Lucia Conte , Barbara Tomasini , Zhejni Vodo , Letizia Pasqui and Fausta Sestini

Abstract

Background: The cause of hyperglycemia, a frequent disorder of glucose homeostasis in very preterm infants, is still unknown.

Objectives: Determine the glucagon and insulin plasma levels at birth in healthy, appropriate for gestational age (AGA) infants born by elective cesarean section (ECS), at different gestational age.

Methods: Glucagon, insulin and the homeostasis model of assessment-insulin resistance (HOMA-IR) index were measured in cord blood in 52 AGA infants divided into three groups: ≤30 weeks, very preterm (VP, n=16); 35–37 weeks, late preterm (LP, n=18); ≥38 weeks, full term (FT, n=18).

Results: In all enrolled infants, Apgar score at 5 min after birth was 7 to 9. In VP infants, glucagon levels were higher than those in LP (533±116 vs. 211±28 pg/mL) (p<0.001) and FT infants (533±116 vs. 226±20 pg/mL) (p<0.001). Insulin levels were higher in VP than in LP (8.61±2.48 vs. 3.98±0.94 mU/L) (p<0.001) and FT infants (8.61±2.48 vs. 4.56±1.2 mU/L) (p<0.001). HOMA-IR index was higher in VP than in LP and FT infants (30.6±10.2 vs. 11.9±3.04 and 13.5±1.6, respectively) (p<0.001).

Conclusion: We concluded that very low gestational age is associated with high glucagon plasma levels and insulin-resistance, which could explain hyperglycemia in the very preterm infants.


Corresponding author: Franco Bagnoli, Department of Molecular Medicine and Delevelopment, Neonatal Intensive Care Unit, University Hospital of Siena, Viale Bracci 16, Siena, Italy, Phone: +39 339612401, Fax: +39 577393547, E-mail:

References

1. Padbury JF, Agata Y, Polk DH, Wang DL, Lam RW, et al. Catecholamine and endorphin responses to delivery in term and preterm lambs. Devel Pharmacol & Ther 1988;11: 44–50.10.1159/000457663Search in Google Scholar

2. Girard JR, Sperling M. Glucagon in the fetus and the newborn. In: Lefebvre PJ, editor. Glucagon. Berlin: Springer, 1983.Search in Google Scholar

3. Menon RK, Sperling MA. Carbohydrate metabolism. Semin Perinatol 1988;2:157–62.Search in Google Scholar

4. Ward Platt M, Deshpande S. Metabolic adaptation at birth. Semin Fetal Neonatal Med 2005;4:341–50.10.1016/j.siny.2005.04.001Search in Google Scholar

5. Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, Vanhole C, Palmer CR, et al. Prevalence and determinants of hyperglycemia in very low birth weight infants: cohort analyses of the NIRTURE study. J Pediatr 2010;5:715–9.10.1016/j.jpeds.2010.04.032Search in Google Scholar

6. Blanco CL, Baillargeon JG, Morrison RL, Gong AK. Hyperglycemia in extremely low birth weight infants in a predominantly Hispanic population and related morbidities. J Perinatol 2006;12:737–41.10.1038/sj.jp.7211594Search in Google Scholar

7. Louik C, Mitchell AA, Epstein MF, Shapiro S. Risk factors for neonatal hyperglycaemia associated with 10% dextrose infusion. Am J Dis Child 1985;8:783–6.Search in Google Scholar

8. Kao LS, Morris BH, Lally KP, Stewart CD, Huseby V, et al. Hyperglycemia and morbidity and mortality in extremely low birth weight infants. J Perinatol 2006;12:730–6.10.1038/sj.jp.7211593Search in Google Scholar

9. Chacko SK, Ordonez J, Sauer PJ, Sunehag AL. Gluconeogenesis is not regulated by either glucose or insulin in extremely low birth weight infants receiving total parenteral nutrition. J Pediatr 2011;6:891–6.10.1016/j.jpeds.2010.12.040Search in Google Scholar

10. Cowett RM, Farrag HM. Selected principles of perinatal-neonatal glucose metabolism. Semin Neonatol 2004;1:37–47.Search in Google Scholar

11. Mitanchez-Mokhtari D, Lahlou N, Kieffer F, Magny JF, Roger M, et al. Both relative insulin resistance and defective islet beta-cell processing of proinsulin are responsible for transient hyperglycemia in extremely preterm infants. Pediatrics 2004;1:537–41.10.1542/peds.113.3.537Search in Google Scholar

12. Bocian-Sobkowska J, Zabel M, Wozniak W, Surdyk-Zasada J. Polyhormonal aspect of the endocrine cells of the human fetal pancreas. Histochem Cell Biol 1999;2:147–53.10.1007/s004180050401Search in Google Scholar

13. Capurro H, Konichezky S, Fonseca D, Caldeyro-Barcia R. A simplified method for diagnosis of gestational age in the newborn infant. J Pediatr 1978;1:120–2.10.1016/S0022-3476(78)80621-0Search in Google Scholar

14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. Homeostasis model assessment insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;7:412–9.10.1007/BF00280883Search in Google Scholar PubMed

15. Bagnoli F, Conte ML, Magaldi R, Rinaldi M, De Felice C, et al. Insulin and glucagon plasma levels in very low birth weight preterm infants of appropriate weight for gestational age. Minerva Pediatr 2009;5:469–75.Search in Google Scholar

16. Johnston DI, Bloom SR. Plasma glucagon levels in the term human infant and effect of hypoxia. Arch Dis Child 1973;6:451–4.Search in Google Scholar

17. Pedraz García C, Pedraz García MJ, Benito Zaballos F, Carbajosa Herrero T, García González P, et al. Levels of insulin, C-peptide and glucagon in the neonatal period. An Esp Pediatr 1983;3:170–6.Search in Google Scholar

18. AvRuskin Th, Lala V, Juan Ch. Umbilical cord immunoreactive glucagon concentrations: relation to birth weight and maternal age. J Pediat Endocr Metabol 1987;2:121–6.Search in Google Scholar

19. Spellacy WN, Buhi WC. Glucagon, insulin and glucose levels in maternal and umbilical cord plasma with studies of placental transfer. Obstet Gynecol 1976;3:291–4.Search in Google Scholar

20. Fekete M, Milner RD, Soltész G, Assan R, Mestyán J. Plasma glucagon, thyrotropin, growth hormone and insulin response to cold exposure in the human newborn. Acta Paediatr Scand 1972;4:435–41.10.1111/j.1651-2227.1972.tb15860.xSearch in Google Scholar PubMed

21. König S, Vest M, Stahl M. Interrelation of maternal and foetal glucose and free fatty acids. The role of insulin and glucagon. Eur J Pediatr 1978;3:187–95.10.1007/BF00444304Search in Google Scholar PubMed

22. Blanco CL, Liang H, Joya-Galeana J, DeFronzo RA, McCurnin D, et al. The ontogeny of insulin signaling in the preterm baboon model. Endocrinology 2010;5:1990–7.10.1210/en.2009-0777Search in Google Scholar PubMed PubMed Central

23. Vuguin PM, Kedees MH, Cui L, Guz Y, Gelling RW, et al. Ablation of the glucagon receptor gene increases fetal lethality and produces alterations in islet development and maturation. Endocrinology 2006;9:3995–4006.10.1210/en.2005-1410Search in Google Scholar PubMed PubMed Central

24. Grasso S, Fallucca F, Mazzone D, Giangrande L, Romeo MG, et al. Inhibition of glucagon secretion in the human newborn by glucose infusion. Diabetes 1983;6:489–92.10.2337/diab.32.6.489Search in Google Scholar PubMed

25. Fowden AL, Forhead AJ, Bloomfield M, Taylor PM, Silver M. Pancreatic alpha cell function in the fetal foal during late gestation. Exp Physiol 1999;4:697–705.10.1017/S0958067099018503Search in Google Scholar

26. Bassett JM. Glucagon, insulin and glucose homeostasis in the fetal lamb. Ann Rech Vet 1977;4:362–73.Search in Google Scholar

Received: 2013-6-4
Accepted: 2013-10-17
Published Online: 2013-11-21
Published in Print: 2014-5-1

©2014 by Walter de Gruyter Berlin/Boston

Downloaded on 8.6.2024 from https://www.degruyter.com/document/doi/10.1515/jpem-2013-0230/html
Scroll to top button